Supreme Court Blocks Purdue Pharma Opioid Settlement, Causing Upheaval

Supreme Court Blocks Purdue Pharma Opioid Settlement, Causing Upheaval

Supreme Court Overturns $6 Billion Purdue Pharma Bankruptcy Settlement in Ruling

The Details of the Supreme Court’s Ruling

In a landmark decision, the Supreme Court has declared that a Purdue Pharma bankruptcy settlement, which was intended to compensate victims of the opioid crisis, contained improper legal protections for the company’s owners. As a result, the $6 billion settlement has been overturned, throwing the future of payments to victims of the opioid crisis into doubt.

The Implications for Victims of the Opioid Crisis

The Supreme Court’s ruling is a significant blow to victims of the opioid crisis who were relying on this settlement to help cover the costs associated with addiction, medical treatment, and other hardships caused by the epidemic. The decision means that payments to victims will likely be delayed or reduced, and they may face additional legal hurdles as they seek to recover damages from Purdue Pharma.

The Legal Issues at Stake

At the heart of the Supreme Court’s ruling is the issue of legal protections for the owners of Purdue Pharma. The settlement included provisions that shielded the company’s owners from future lawsuits related to the opioid crisis. The court decided that these provisions were too broad, and that they unfairly protected the owners from legal consequences related to their role in the crisis.

The Role of Purdue Pharma in the Opioid Crisis

Purdue Pharma, the makers of the highly addictive painkiller OxyContin, has been widely blamed for its role in the opioid crisis. The company has faced numerous lawsuits and investigations from state and federal authorities, alleging that it engaged in deceptive and illegal marketing practices to promote the drug. The bankruptcy settlement was seen as an important step towards holding the company accountable for its actions.


The Supreme Court’s ruling is a setback for victims of the opioid crisis who were counting on this settlement to provide some measure of justice and compensation. It underscores the complicated legal issues surrounding the crisis, and the challenges of holding companies like Purdue Pharma accountable for their role in it. Moving forward, it will be important for lawmakers and advocates to continue to push for policies and solutions that address the root causes of the epidemic and support those most affected by it.

Originally Post From

Read more about this topic at
Opioid Maker’s Bankruptcy Plan Would Cut Payments to …
Handling chronic illness and trauma | 2022-04-14

DUI Checkpoint Set Up in Lodi to Reduce Impaired Driving

“TM Investors Take Lead in Toyota Motor Corporation Securities Fraud Case”